Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890747972> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W2890747972 abstract "e19045 Background: Hematologic cancers can present with severe issues such as airway compromise, hypercalcemia, etc. Due to high drug costs and payment concerns, therapies that are inexpensive but effective are necessary. Within our institution, we utilize hyperfractionated cyclophosphamide (cyclophosphamide 300 mg/m 2 IV q 12 hours X 6) [HyperC] for these patients. We opted to see if this approach is justified. Methods: We reviewed data via our EMR of people who received HyperC. Data was limited to urgent therapy. Data was collected from 2015-2017. The cost of therapy was also looked at relative to other therapies with our pharmacy team. Categories are as per the charts below. Results: See Table. Conclusions: HyperC is cost effective and efficacious for patients who need urgent therapy. [Table: see text][Table: see text][Table: see text]" @default.
- W2890747972 created "2018-09-27" @default.
- W2890747972 creator A5028358290 @default.
- W2890747972 creator A5030208423 @default.
- W2890747972 creator A5039180550 @default.
- W2890747972 creator A5089053922 @default.
- W2890747972 date "2017-05-20" @default.
- W2890747972 modified "2023-09-27" @default.
- W2890747972 title "Hyperfractionated cyclophosphamide as urgent therapy: A single institution experience." @default.
- W2890747972 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.e19045" @default.
- W2890747972 hasPublicationYear "2017" @default.
- W2890747972 type Work @default.
- W2890747972 sameAs 2890747972 @default.
- W2890747972 citedByCount "0" @default.
- W2890747972 crossrefType "journal-article" @default.
- W2890747972 hasAuthorship W2890747972A5028358290 @default.
- W2890747972 hasAuthorship W2890747972A5030208423 @default.
- W2890747972 hasAuthorship W2890747972A5039180550 @default.
- W2890747972 hasAuthorship W2890747972A5089053922 @default.
- W2890747972 hasConcept C126322002 @default.
- W2890747972 hasConcept C143998085 @default.
- W2890747972 hasConcept C177713679 @default.
- W2890747972 hasConcept C2776694085 @default.
- W2890747972 hasConcept C2776755627 @default.
- W2890747972 hasConcept C71924100 @default.
- W2890747972 hasConceptScore W2890747972C126322002 @default.
- W2890747972 hasConceptScore W2890747972C143998085 @default.
- W2890747972 hasConceptScore W2890747972C177713679 @default.
- W2890747972 hasConceptScore W2890747972C2776694085 @default.
- W2890747972 hasConceptScore W2890747972C2776755627 @default.
- W2890747972 hasConceptScore W2890747972C71924100 @default.
- W2890747972 hasLocation W28907479721 @default.
- W2890747972 hasOpenAccess W2890747972 @default.
- W2890747972 hasPrimaryLocation W28907479721 @default.
- W2890747972 hasRelatedWork W1971240871 @default.
- W2890747972 hasRelatedWork W1985915181 @default.
- W2890747972 hasRelatedWork W2021899231 @default.
- W2890747972 hasRelatedWork W2023377026 @default.
- W2890747972 hasRelatedWork W2024057322 @default.
- W2890747972 hasRelatedWork W2073705517 @default.
- W2890747972 hasRelatedWork W2163734049 @default.
- W2890747972 hasRelatedWork W2188653293 @default.
- W2890747972 hasRelatedWork W2203655394 @default.
- W2890747972 hasRelatedWork W2265397022 @default.
- W2890747972 hasRelatedWork W2407134812 @default.
- W2890747972 hasRelatedWork W2412772131 @default.
- W2890747972 hasRelatedWork W2989922649 @default.
- W2890747972 hasRelatedWork W2991038709 @default.
- W2890747972 hasRelatedWork W632452041 @default.
- W2890747972 hasRelatedWork W758033410 @default.
- W2890747972 hasRelatedWork W2185659611 @default.
- W2890747972 isParatext "false" @default.
- W2890747972 isRetracted "false" @default.
- W2890747972 magId "2890747972" @default.
- W2890747972 workType "article" @default.